Pay in 4 interest-free payments of $6.71 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Important: HSA/FSA eligibility for tirzepatide requires a qualifying medical diagnosis (obesity or Type 2 diabetes)
"We don't know how effective it's going to be
Numerous medical experts and policymakers have urged users to exercise caution, pointing to a lack of adequate research into their long-term effects, and the risks of self-injecting with untested, unregulated drugs
Wegovy 2.4 mg FlexTouch solution for injection in pre-filled pen Summary of Product Characteristics (SmPC)
US$ 26.27
US$ 26.25
US$ 29.17
US$ 27.08
